Amyris Inc (fka AMRSQ)

[cashcow3]

NEW- NEWS-

ACI Association has initiated research coverage on Amyris, Inc. (NASDAQ:AMRS). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.

Today, membership is open to readers on a complementary basis at the following URL: http://www.aciassociation.com/?c=AMRS

Highlights from our AMRS Report include:

-- First Agreement in Food Sector - On July 16, 2015, Amyris, Inc. announced that it has entered into a multi-year, multi-million-dollar collaboration agreement with a global food ingredients supplier. This partnership represents its first collaboration in the growing food ingredients sector. Following the announcement, the Company's shares soared 11.73% to close the session at $2.00.

-- Details of the Agreement - Under the agreement, the partner, whose name was not disclosed by the Company, will provide funding for the development program, which will be executed by Amyris. Additionally, the agreement includes a long-term value share provision in regard to future end-market product sales by the partner.[color=red][/color]

-- Management Statements - Commenting on the partnership, John Melo, President and CEO of Amyris, stated, "We're excited with the continued momentum in executing our plan with growing our collaboration partnerships. This collaboration adds to our current portfolio of collaboration partners and our growing portfolio of over 20 products under agreement with more than 10 partners." Melo added, "We are on track to introduce three new commercial products this year for our partners as a result of our earlier collaborations. Collaborations continue to fund our direct R&D costs and provide strong product revenue growth."

-- Other Recent Agreements - On June 25, 2015, the Company had announced an exclusive re-seller agreement for its Neossance® cosmetic ingredients with Dinaco Importação Comércio S.A. - a Brazilian company specializing in cosmetic product distribution for the Brazilian market. As part of the agreement, Dinaco, which distributes products and ingredients for many of the world's most important cosmetics and other manufacturers, would purchase and exclusively re-sell Amyris's Neossance® Squalane and Neossance® Hemisqualane products throughout Brazil. Previously, on June 9, 2015, the Company announced the signing of a Letter of Intent (LOI) to establish an agreement for Amyris to supply a key starting material for an active pharmaceutical ingredient to Mumbai, India-based Ipca Laboratories Ltd.

To find out how this influences our rating on Amyris, Inc., read the full report in its entirely here: http://www.aciassociation.com/?c=AMRS